Stem Cell Research and Regenerative Medicine: Meeting Report from the Royan International Stem Cell Congress 2025

The 21st Royan International Stem Cell Congress highlighted the rapid progress in translating regenerative medicine into clinical applications, emphasizing a multidisciplinary approach. Key advancements included the development of primate and human embryo models, cross-species reprogramming, exosome-based therapeutics, and the use of AI for patient stratification and drug repurposing. Bioengineering sessions focused on innovative biomaterials, non-viral gene delivery, and scalable microfluidic platforms to improve therapeutic safety and production. The congress also addressed regulatory challenges and the need for a supportive ecosystem for clinical adoption, underscoring the integration of foundational biology and emerging technologies in advancing stem cell therapies.